Compounds > bromopyruvate
Page last updated: 2024-08-25

bromopyruvate and Infections, Staphylococcal

bromopyruvate has been researched along with Infections, Staphylococcal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imperi, F; Pisa, F; Visca, P1
Boradia, VM; Chopra, S; Das, S; Dasgupta, A; Gani, Z; Kumar, A; Patidar, A; Raje, CI; Raje, M; Singh, AK; Thakare, R1

Other Studies

2 other study(ies) available for bromopyruvate and Infections, Staphylococcal

ArticleYear
The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus.
    International journal of antimicrobial agents, 2019, Volume: 53, Issue:4

    Topics: Anti-Bacterial Agents; Antimetabolites; Biofilms; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pyruvates; Staphylococcal Infections; Staphylococcus aureus

2019
Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial.
    The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Repositioning; Enzyme Inhibitors; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Mice, Inbred BALB C; Microbial Viability; Mycobacterium tuberculosis; Pyruvates; Staphylococcal Infections; Staphylococcus aureus; Transferrin; Treatment Outcome

2019